FDA Investigator Lori M Newman

Lori M Newman has conducted inspections on 21 sites in 2 countries as of 07 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
21
Last Inspection Date:
07 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100003529
Countries of Inspections:
United States of America, India
FDA Investigators that have inspected at least one site in common with Lori M Newman:
Abdur Rafay Shareef, Allison A Aldridge, PhD, Alois P Provost, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Anita R Michael, Azeezat M Lawal, Barbara G Swan, Barbara Jwilimczyk Macri, Carla C Cummins, Carla C Tuite, Carlos Chavez, Cassandra L Abellard, Charisse K Green, Charles R Cote, RIC, Christian F Gomez Lugo, Christina K Theodorou, Constance Desimone, Craig D Zagata, Daniel J Grabicki, Daniel L Zheng, Daryl A Dewoskin, David A Oluwo, Debra I Love, Devon Jenkins, Dr. Erika A Pfeiler, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Eileen A Liu, Ellen P Madigan, Erika V Butler, Felix Maldonado, Garry H Stewart, Gary J Hagan, Hasan A Irier, PhD, James M Mason, James W Whitney, Jason B Prosser, John A Gonzalez, John P Mistler, John R Tuohig, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Joy Rkozlowski Klena, Juan Rjimenez Garcia, Justine M Corson, Justine Tomasso, Karen E D'orazio, Karen Mcnabb Noon, Katherine Szestypalow, Kenneth H Williams, Kent A Conforti, Kham Phommachanh, Kim Lthomas Cruse, Krystyna M Kitson, Larry K Austin, Lauren N Barber, Laurie B Frazier, LCDR Chad N Thompson, LCDR Debra Emerson, Leanna M Slarsky, Leo B Zadecky, Loretta Nemchik, Lori A Holmquist, LT John M Mastalski, Marea K Harmon, Margaret M Doherty, Margaret M Sands, Mark R Mcclain, Mary Jeanet Mcgarry, Matthew B Casale, Matthew C Watson, Maura Rooney, Meredith L Miller, Michael J Casey, Nancy M Espinal, Nealie C Newberger, Paige R Mccoy, Paraluman S Leonin, Paul L Bellamy, Paul P Geraci, Paula M Laplant, Philip Kreiter, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Rachael A Moliver, Ramon E Martinez, Richard B Mcaroy, Richard H Penta, Richard L Rutherford, Robert J Martin, Rochelle L Cross, Roger F Zabinski, Rory K Geyer, Rosario D'costa, Russell J Glapion, Samuel K Mathew, Samuel Mathew, Sean R Marcsisin, Sony Mathews, Stacey S Degarmo, Syed N Ali, Taichun Qin, PhD, Tamil Arasu, PhD, Uttaniti Limchumroon (Tom), William J Leonard, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Yvonne Y Wu

Lori M Newman's Documents

Publish Date Document Type Title
April, 2024 FDA 483 Cipla Ltd. - Form 483, 2024-04-04
January, 2024 FDA 483 AIRGAS USA, LLC - Form 483, 2024-01-12
February, 2023 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2023-02-09
November, 2021 FDA 483 SterRx, LLC - Form 483, 2021-11-04
March, 2024 FDA 483 Zydus Lifesciences Limited - Form 483, 2024-03-27
June, 2021 FDA 483 Pharmasol Corporation - Form 483, 2021-06-14
July, 2022 FDA 483 Medical-technical Gases, Inc. - Form 483, 2022-07-08
April, 2022 FDA 483 US Specialty Formulations LLC - Form 483, 2022-04-26
October, 2022 FDA 483 ALK-ABELLO, INC. - Form 483, 2022-10-21
December, 2023 FDA 483 University System of New Hampshire - Form 483, 2023-12-05
August, 2023 FDA 483 Lohxa - Form 483, 2023-08-03
June, 2021 FDA 483 Pharmasol Corporation - Form 483, 2021-06-14
November, 2023 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2023-11-22
June, 2022 FDA 483 AIRGAS USA, LLC - Form 483, 2022-06-08
February, 2024 FDA 483 FreeThink Technologies Inc. - Form 483, 2024-02-21
June, 2023 FDA 483 W.S. BADGER COMPANY, INC. - Form 483, 2023-06-01
July, 2021 FDA 483 Lohxa - Form 483, 2021-07-19
May, 2024 FDA 483 Tom's of Maine, Inc. - Form 483, 2024-05-22
July, 2024 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2024-07-29
September, 2024 FDA 483 Arkema Inc. - Form 483, 2024-09-24
November, 2024 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2024-12-13
January, 2025 FDA 483 SpecGx LLC - Form 483, 2025-01-17
November, 2024 EIR N-Molecular, Inc. dba SOFIE - EIR, 2024-12-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more